Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

@article{Sendi1999CostEO,
  title={Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.},
  author={Pedram P Sendi and Heiner C. Bucher and Thomas Harr and Bruce A. Craig and Martin Schwietert and Dominik Pfluger and Amiram Gafni and Manuel Battegay},
  journal={AIDS},
  year={1999},
  volume={13 9},
  pages={
          1115-22
        }
}
BACKGROUND Highly active antiretroviral therapy (HAART) has become the most important strategy for treating HIV infection in developed countries; however, access to HAART might vary under different funding policies. The Swiss health care system provides unrestricted access to HAART for all patients who need these newer combination therapies. This study investigated the impact of this funding policy on the society and health care system. METHODS A cost-effectiveness analysis with natural… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 32 CITATIONS

Similar Papers

Loading similar papers…